Vintoperol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVintoperol
Drug Alias Namevintoperol长春培醇vintoperolumRT-3003RGH-2981
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersAlpha adrenergic receptor antagonists
TargetsVoltage-gated calcium channelAlpha adrenergic receptor
Therapy Area/IndicationsPeripheral Arterial DiseaseArterial Occlusive Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGedeon RichterTakata Seiyaku
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakata SeiyakuGedeon Richter Plc
Active IndicationsN/A
Inactive IndicationsPeripheral Arterial DiseaseArterial Occlusive Diseases

Other Information

ATC CodeN/A
Related LinksN/A